Stata program version 14
STATA program version 14 is a comprehensive statistical software package developed by StataCorp. It is designed to facilitate data analysis, management, and visualization. The program offers a wide range of statistical tools and techniques, including regression analysis, time series modeling, and data manipulation capabilities. STATA version 14 is suitable for a variety of research and professional applications across multiple disciplines.
Lab products found in correlation
18 protocols using stata program version 14
Predicting Postoperative Liver Failure
Hernia Recurrence and Risk Factors Analysis
Statistical Analysis of Patient Outcomes
Prognostic Role of Platelet-Lymphocyte Ratio
Survival Analysis of Surgical Oncology
The follow-up time we considered was from the date of surgery until the day of death, or the last day of follow-up in patients who did not die. This was because the tumour registry did not contain any clear definition of the date of diagnosis. Survival analysis was performed using the Kaplan–Meier method and the log-rank test was implemented to estimate the differences between groups in terms of OS and DFS. Probability values of P < 0.05 were accepted as the statistical significance cut-off level. Statistical analysis was carried out with the IBM SPSS Statistics® program version 22 (IBM®, Armonk, New York, USA). The CUSUM curves were calculated using the STATA® program version 14 (StataCorp LP®, College Station, Texas, USA).
Statistical Analysis of Experimental Data
Impact of Scene Time on Mortality
Continuous data were summarized as mean and standard deviation, median, and interquartile range as appropriate. Student’s t-test or Wilcoxon Rank Sum test was employed to identify significant differences between the patients who died within 24 h and those who did not, based on the data distribution. Categorical variables were analyzed with the Chi-square test or exact probability test and reported as percentages. Multivariable risk regression analysis was used to evaluate the independent effect of scene time on 24-h mortality. A P < 0.05 was statistically significant. We used STATA program version 14 (StataCorp, College Station, TX, USA) for data analysis.
Comorbidities and CAR Development
Statistical Analysis of Risk Factors
Surgical Management of cSCCs in EB
We collected the following clinical data for each subject: age and sex, date of cSCC diagnoses, number of cSCCs, relapses, site of the neoplasm, number of surgical interventions needed for radical excision, use of dermal substitutes, and infections in the postoperative period.
Statistical analysis was performed with the STATA program, version 14 (StataCorp LP 4905 Lakeway Drive College Station, Texas 77,845 USA). Numerical data were expressed as mean and standard deviation or median and range as appropriate. Qualitative data were expressed as frequency and percentage. The chi‐square test (Fisher’s exact test) was used to examine the relation between qualitative variables. Survival analysis was done using the Kaplan–Meier method, and a comparison between two survival curves was done using the log‐rank test. A P value of <0.05 was considered significant.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!